Onco Cell Therapy summit Europe

02/11 - 03/11/2022

Europe is a powerhouse of research but has been struggling to keep pace with development in the US. Get multiple perspectives during panel discussions on how to attract investment from C-suite executives and investors and explore European regulatory and reimbursement challenges for the cell therapy field. This is your unique opportunity to:

  • Meet with over 200 of Europe‚Äôs leading innovators and investors to drive partnerships, collaborations and drive adoptive cell therapies to the market

  • Address durability, reduce exhaustion, and build in optimal approaches for targeting antigen heterogeneity to hit the tumour microenvironment

  • Explore genome-editing, iPSC-derived approaches and management strategies for chromosomal abnormalities and translocations for allogeneic cell therapy development

  • Establish robust, scalable and flexible vein-to-vein processes to enhance just in time delivery of cell therapies

Following colleague will be present:

  • Jessika Wynendaele - Business Development Manager

onco amsterdam picture

Meet our scientists

With more than 20 years of experience in insight-based analytics, we drive your drug development forward.

Contact us